Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein.

Vaccine
Yoshihiko MurataEdward E Walsh

Abstract

To characterize the humoral response to the unglycosylated central region of the respiratory syncytial virus (RSV) attachment (G) protein, we generated glutathione S-transferase (GST)-RSV G subdomains (central core (CC), residues 151-190; proximal central core (PCC), 151-172; and distal central core (DCC), 173-190) to screen paired sera from RSV subtype A- or B-infected adults in hospitalized or outpatient settings. Following RSV infection, a >or=4-fold increase in homo- and heterosubtypic IgG response was noted in most subjects against the RSV G CC and PCC regions; in contrast, such titer increases against the RSV G DCC was only noted in a homosubtypic manner. Our results have implications for RSV G-based serological diagnostics and vaccine development.

References

Jan 1, 1992·Journal of Medical Virology·A R Falsey, E E Walsh
Sep 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·E NorrbyR A Lerner
Jul 31, 2001·Nature Immunology·R A TrippL J Anderson
Dec 19, 1964·British Medical Journal·P S GARDNERA H WALL
May 4, 2004·Journal of Medical Virology·Edward E Walsh, Ann R Falsey
Jun 25, 2004·The Journal of Infectious Diseases·Edward E Walsh, Ann R Falsey
Aug 11, 2004·Virology·Patricia M A de GraaffGrada M van Bleek
Apr 29, 2005·The New England Journal of Medicine·Ann R FalseyEdward E Walsh
Jun 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Fernando P PolackSteven R Kleeberger
Feb 7, 2009·The New England Journal of Medicine·Caroline Breese HallPeter Szilagyi

❮ Previous
Next ❯

Citations

Aug 24, 2013·Expert Review of Respiratory Medicine·Patricia A JorqueraRalph A Tripp
Feb 23, 2017·Annual Review of Immunology·Peter J M OpenshawCecilia Johansson
Apr 7, 2017·PloS One·Jeong-Yoon Lee, Jun Chang
Oct 10, 2020·PLoS Pathogens·Jiachen HuangJarrod J Mousa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.